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Introduction. The objective is to determine the clinical and experimental evidences of the renal responses to warm and cold
ischemia,kidneytolerability,andavailablepracticaltechniquesofprotectingthekidneyduringnephron-sparingsurgery.Materials
and methods. Review of the English and non-English literature using MEDLINE, MD Consult, and urology textbooks. Results and
discussion. There are three main mechanisms of ischemic renal injury, including persistent vasoconstriction with an abnormal
endothelial cell compensatory response, tubular obstruction with backﬂow of urine, and reperfusion injury. Controversy persists
on the maximal kidney tolerability to warm ischemia (WI), which can be inﬂuenced by surgical technique, patient age, presence
of collateral vascularization, indemnity of the arterial bed, and so forth. Conclusions. When WI time is expected to exceed from 20
to 30 minutes, especially in patients whose baseline medical characteristics put them at potentially higher, though unproven, risks
of ischemic damage, local renal hypothermia should be used.
Copyright © 2008 Fernando P. Secin. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Nephron-sparing surgery in the oncologic setting entails
complete local resection of a renal tumor while leaving the
largest possible amount of normal functioning parenchyma
in the involved kidney. Diﬀerent surgical techniques can be
employed for performing partial nephrectomy, but all of
them require adherence to basic principles of early vascular
control, avoidance of ischemic renal damage with complete
tumor excision with free margins, precise closure of the
collecting system, careful hemostasis, and closure with or
without tamponading of the renal defect with adjacent fat,
fascia, or any available artiﬁcial sealant [1, 2].
Observanceofalltheseprinciplesisextremelyimportant,
however, prevention of ischemic renal damage is a key to the
ﬁnal success of the procedure. Ischemia is the leading cause
of postoperative acute and chronic renal failure in patients
undergoing nephron sparing surgery, for which no speciﬁc
medical treatment modality has been established to date.
By the same token, surgeons need to apply transitory
occlusion of the renal artery as it not only diminishes
intraoperative parenchymal bleeding but also improves
visualization and facilitates access to intrarenal structures
by causing the kidney to contract and by reducing renal
tissuefullness.Surgeonsperformingthisapproachrequirean
understandingofrenalresponsestowarmischemia(WI)and
available methods of protecting the kidney when the period
of arterial occlusion exceeds normal parenchyma tolerability
[3].
In order to decrease the exposure of the spared
parenchymatoischemia,thesurgeonshouldhaveacomplete
preoperative and intraoperative assessment of the relation-
ship of the tumor and its vascular supply to the collecting
system and adjacent normal renal parenchyma [4–6].
There is no question that the less the better, whenever
the philosophy to preserve as much functioning renal tissue
as possible is followed. This manuscript seeks to determine
theclinicalandexperimentalevidencesoftherenalresponses
to warm and cold ischemia, kidney tolerability, and available
practical techniques of protecting the kidney when the
period of arterial occlusion surpasses that which may be
safely tolerated during renal nephron sparing surgery.
2. MATERIAL AND METHODS
Biomedical and related databases were queried includ-
ing MEDLINE, MD Consult, and urology textbooks.
Manuscripts and library archives were retrieved from the2 Advances in Urology
Nathan Cummings Center, Memorial Sloan-Kettering Can-
cer Center, NY, USA.
A Medline search in combination with additional
references of non-Medline-indexed journals included the
following key words: “nephron-sparing surgery,” “partial
nephrectomy,” “warm ischemia and kidney,” and “ischemia
time and kidney,” as well as links to related articles. Non-
English articles and letters to editors were reviewed as well.
These references formed the basis of the article. Following
selection and deletion based on relevance of the subject
and importance of the studies, a library of 115 references
remained.
3. RESULTS AND DISCUSSION
3.1. Intraoperativerenalischemia:
pathophysiologyofinjury
In recent years, there have been signiﬁcant insights into the
pathophysiologic process of renal ischemia [7, 8]. Ischemic
insult to the kidney often results in damage to cells of
nephron and renal vasculature. Cells are lost through the
processes of necrosis and apoptosis, inevitably leading to
renal failure. Renal failure is characterized by a decline in
glomerular ﬁltration rate, retention of nitrogenous waste
products, perturbation of extra cellular ﬂuid volume, and
electrolyte and acid-base homeostasis. Renal failure is only
diagnosed when these pathophysiologic perturbations are
advanced enough to manifest biochemical abnormalities
in the blood. The pathophysiologic response to cell death
dictates the prevailing level of renal functional impairment
[9]. Therefore, a clear understanding of the extent of post
ischemic kidney damage and associated inﬂammation is
needed to prevent this hitherto intractable condition, which
will ultimately impact on overall survival [10].
For understanding and didactic purposes, three interre-
lated main mechanisms through which ischemia damages
the kidney are herein described based on a recent review
by Abuelo [7]. One mechanism is merely vascular, caused
by persistent vasoconstriction and an abnormal response
of endothelial cells to compensatory means. The second
is obstructive, where soughed tubular epithelial cells and
brush-border-membrane debris form casts that obstruct
tubules, and glomerular ﬁltrate leaks from the tubular
lumen across denuded tubular walls into capillaries and the
circulation (back-leak) causing a reduction in the “eﬀective”
GFR, where the latter is deﬁned as the rate at which ﬁltrate
is delivered into ﬁnal urine. The third has to do with
reperfusion injury after blood ﬂow is restored [7, 11].
3.1.1. Vascularmechanism
Both animal and human studies have found that a multi-
inﬂammatory response is involved in ischemia/reperfusion
injury of the kidney [12]. The inﬂammatory reaction
incurred after an ischemic insult precipitates more damage
to the tissue and impedes intrarenal blood ﬂow caused
by vasoconstriction and vascular congestion, leading to a
vicious cycle [13].
This damage mainly takes place in endothelial cells of the
peritubularcapillaries,especiallyintheoutermedulla,which
is marginally oxygenated under normal circumstances. This
oxidant injury, together with a shift in the balance of vasoac-
tive substances toward vasoconstrictors such as endothe-
lin, results in vasoconstriction, congestion, hypoperfusion,
and expression of adhesion molecules. The expression of
adhesion molecules, in turn, initiates leukocyte inﬁltration,
augmented by proinﬂammatory and chemotactic cytokines
generated by ischemic tubular cells [7].
Inciting stimuli induce kidney macrophages and prob-
ably renal parenchymal cells to release inﬂammatory
cytokines, such as tumor necrosis factor-α (TNF-α)a n d
interleukin-1 (IL-1). TNF-α and IL-1 promote renal
parenchymal damage by directly inducing apoptosis in
epithelial cells, recruitment of neutrophils that release reac-
tive oxygen metabolites and proteases, and up regulating
adhesion receptors on endothelial cells and leukocytes [14,
15]. These cytokines also stimulate renal cortical epithelial
cells to release the chemoattractant interleukin-8 [16, 17].
The arrival of additional leukocytes obstructs the micro-
circulation and releases more cytotoxic cytokines, reactive
oxygen species, and proteolytic enzymes, which damage the
tubular cells [7].
Endothelial injury results in cell swelling and enhanced
expression of cell adhesion molecules. This, together
with leukocyte activation, leads to enhanced leukocyte-
endothelial cell interactions, which can promote injury
and swelling of the endothelial cell. Endothelial swelling
contributes to the production of local factors promoting
vasoconstriction and adds to the eﬀects of vasoconstriction
and tubule cell metabolism by physically impeding blood
ﬂow, perpetuating that vicious cycle [18].
Heterogeneity of intrarenal blood ﬂow contributes to
the pathophysiology of ischemic renal failure. An imbalance
between the vasodilator nitric oxide and the vasoconstrictor
endothelin impairs medullary blood ﬂow, especially in the
outer medulla, where tubules have high oxygen require-
ments,resultingincellularinjuryduetoamismatchbetween
oxygen delivery and demand. Endothelial activation and
injury together with increased leukocyte-endothelial cell
interactions and activation of coagulation pathways may
have a greater eﬀect on outer medullary ischemia than arte-
riolar vasoconstriction, as there can be markedly impaired
oxygen delivery to the outer medulla despite adequate renal
blood ﬂow [18].
The arteriolar response to vasoactive substances can
also be altered during endothelial injury. The basal tone
of arterioles is increased in post ischemic kidneys as well
as their reactivity to vasoconstrictive agents. These arteri-
oles also have decreased vasodilatory responses compared
with arterioles from normal kidneys. Alterations in local
levels of vasoconstrictors (angiotensin II, thromboxane A2,
leukotrienes, adenosine, endothelin-1) have been implicated
in abnormal vascular tone [19]. Angiotensin II seems to
play a key role by activating endothelin B or prostaglandin
H2-thromboxane A2 receptors. Systemic endothelin-1 levels
increasewithischemia,andadministrationofantiendothelin
antibodies or endothelin receptor antagonists has been
reported to protect against ischemia-reperfusion injury
[20]. Saralasin, an angiotensin II receptor antagonist, couldFernando P. Secin 3
also attenuate angiotensin II vasoconstricting eﬀect [21].
Nitric oxide, an endothelial-derived relaxing factor, plays a
theoretical protective role against ischemic renal injury, by
means of its vasodilatory eﬀect and by decreasing endothe-
lin expression and secretion in the vascular endothelium.
Of interest, endothelial nitric oxide synthase is inhibited
during endothelial injury [22]. A combination therapy
consisting of 5-aminoimidazole-4-carboxamide-1-beta-D-
ribonucleoside (AICAR) and N-acetyl cysteine (NAC), drugs
that inhibit the induction of proinﬂammatory cytokines
and nitric oxide synthase, and block tumor necrosis factor-
alpha induced apoptotic cell death, has shown to attenuate
ischemia-reperfusion injury in a canine model of autolo-
gous renal transplantation [23]. Early studies showed no
conclusive evidence that vasodilators (such as diltiazem or
dopamine) or other compounds have any clinical utility
in either preventing or treating ischemic renal failure in
humans thus far [24–26]. More recently, however, the highly
selective dopamine type 1 agonist fenoldopam mesylate
[27] and the antianginal medication trimetazidine [28]
appeared to aid in restoring renal function to baseline values
in patients with prolonged WI time. Further research is
needed.
3.1.2. Obstructivemechanism
Normally, the cells are bathed in an extra cellular solution
high in sodium and low in potassium. This ratio is main-
tained by a sodium pump (Na+-K + ATPase pump) which
uses much of the adenosine triphosphate (ATP) energy
derived from oxidative phosphorylation. ATP is required for
the cellular sodium pump to maintain a high intracellular
concentration of potassium and a low concentration of
sodium. The sodium pump eﬀectively makes Na+ an imper-
meant outside the cell that counteracts the colloidal osmotic
pressurederivedfromintracellularproteinsandotheranions
[29].
Theischemicinsultcausesafailureofoxidativephospho-
rylation and ATP depletion, leading to malfunctioning of the
sodium pump. When the sodium pump is impaired, sodium
chloride and water passively diﬀuse into the cells, resulting
in cellular swelling and the “no-reﬂow” phenomenon after
renal reperfusion. Cellular potassium and magnesium are
lost, calcium is gained, anaerobic glycolysis and acidosis
occur, and lysosomal enzymes are activated. This results in
cell death. During reperfusion, hypoxanthine, a product of
ATP degradation, is oxidized to xanthine with the formation
of free radicals that cause further cell damage [29]. (See
later.)
As mentioned, the mechanism whereby ischemia and
oxygen depletion injure tubular cells starts with ATP deple-
tion, which activates a number of critical alterations in
metabolism,causingcytoskeletaldisruptionandlossofthose
properties that normally render the tubule cell monolayer
impermeable to certain components of ﬁltrate. Cytoskeletal
disruption causes not only loss of brush-border microvilli
and cell junctions but also mislocation of integrins and
the sodium pump from the basal surface to the apical
surface.
In addition, impaired sodium reabsorption by injured
tubular epithelial cells increases the sodium concentration
in the tubular lumen. The increased intratubular sodium
concentration polymerizes Tamm-Horsfall protein, which is
normally secreted by the loop of Henle, forming a gel and
contributing to cast formation. As a result, brush-border
membranes and cells slough obstruct tubules downstream.
As mentioned before, these debris form casts that obstruct
tubules, and glomerular ﬁltrate leaks from the tubular
lumen across denuded tubular walls into capillaries and the
circulation (back-leak) causing a reduction in the “eﬀective”
GFR. ATP depletion also activates harmful proteases and
phospholipases, which, with reperfusion, cause oxidant
injury to tubular cells, the so-called reperfusion injury
[7].
3.1.3. Reperfusioninjury
WI insult followed by restoration of blood ﬂow to the
ischemic tissue frequently results in a secondary reperfusion
injury. Despite WI causing signiﬁcant renal dysfunction,
reperfusion injury has been shown to be as damaging or
even more detrimental than renal ischemia itself, producing
an inﬂammatory response that worsens local kidney damage
and leads to a systemic insult [30, 31].
The reperfusion injury can be mediated by several
mechanisms including the generation of reactive oxygen
species, cellular derangement, microvessel congestion and
compression, polimorphonuclear (PMN)-mediated damage,
and hypercoagulation. Reperfusion with the resulting rein-
troduction of molecular oxygen of constricted microvessels
leads to congestion and red cell trapping. This vascular eﬀect
can reduce renal blood ﬂow by as much as 50% [32].
During the reperfusion period, superoxide production
in the kidney is markedly enhanced by the transformation
of xanthine dehydrogenase to xanthine oxidase and the
increase in free electrons in mitochondria, prostaglandin
H, and lipoxygenase with the coexistence of NAD(P)H
and inﬁltrated neutrophils. Superoxide raises the following
chainreactions,producinghydroxylradicalsorotherreactive
oxygen species (ROSs), or interacts with nitric oxide (NO),
which is produced by macrophage inducible NO synthase,
generating a highly toxic radical peroxynitrite. These ROS
and NO derived species consume tissue antioxidants and
decrease organ reducing activity [33].
Theexactmagnitudeofreperfusioninjuryisstillunclear.
Some authors state that the role of free radicals mediated
injury in kidneys may not be as signiﬁcant as in other organs
given the low relative activity of renal xanthine oxidase
compared with the high endogenous activity of superoxide
dismutase [29].
Notwithstanding, nicaraven (N,N9-propylenebisnicotin-
amide), a drug that may actively trap free radicals and
prevent vascular constriction due to lipid peroxide [34]a n d
edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one, MCI-
186), a synthetic free radical scavenger, have shown in vitro
experiments to protect endothelial cells against ischemic
injury in diﬀerent organs, including ischemically damaged
kidneys [35, 36]. Clinical studies are eagerly awaited.4 Advances in Urology
4. FOR HOW LONG CAN THE KIDNEY TOLERATE
WARM ISCHEMIA?
Despite several animal studies [37–39] and clinical reports
[40, 41] demonstrating kidney tolerance to warm ischemia
times beyond 30 minutes, concern still remains regarding
the potential for full-renal function recovery after this
time period [42]. The stoic 30-minute cutoﬀ has been
questionedbysomeauthors[43]onthegroundsthatkidneys
harvested from nonheart beating donors (NHBDs) have
shown favorable recovery of renal function in transplanted
kidneys that sustained warm ischemia times well over 30
minutes [44–46]. Nishikido et al. [45] found that the risk
factors aﬀecting signiﬁcant graft loss were WI time more
than 20 minutes, donor age above 50 years, and donor
serum creatinine at admission above 1.0mg/dL. Today, most
nonheart beating donor programs currently exclude those
donors with a WI time exceeding 40 minutes [45, 47–49].
Although laparoscopic surgeons are gaining further
experience and are more ambitious to perform partial
nephrectomy for larger and deeper tumors, the 30-minute
cutoﬀstillremainstheacceptedsafelimittimebeyondwhich
irreversible kidney damage occurs in the absence of renal
cooling [50–52].
Although early observations in dog models showed that
there may be substantial variation in kidney tolerance up to
two or three hours of ischemia [53] there is no doubt that
the extent of renal damage after transitory arterial occlusion
exclusively depends on the duration of the ischemic insult
[25, 54, 55]. The literature also demonstrates that, even
within a tolerable period of WI, the longer the WI time the
longer it takes for the kidney to recover (or approach) its
preoperative function [55]. Notwithstanding, the maximum
tolerable limit of renal warm ischemia time that can render
complete function recovery remains to be established in
humans.
The study by Ward [56] is commonly cited by opinion
leaders to state a maximum 30-minute tolerance of the
kidney to WI. These authors showed in dogs that warm
ischemic intervals of up to 30 minutes can be sustained
with eventual full recovery of renal function. However, this
study was not strictly designed to establish the most accurate
length of time a kidney would be able to sustain reversible
damage following ischemic injury. What the authors actually
concluded was that no additional protection to ischemia
could be gained by cooling below 15 degrees. Thus, they
recommended 15 degrees as the optimum temperature for
use in clinical renal hypothermia.
Research in rats, pigs, and monkeys has also been
conducted by other investigators. Laven et al. [38]f o u n d
renal resilience to WI beyond the traditionally accepted 30
minutes in a solitary kidney pig model. Prolonged renal WI
time increased the incidence of renal dysfunction during the
initial72hoursaftertheischemicinsult.However,by2weeks
after the WI insult renal function returned to baseline in
the 30, 60, and 90-minute WI groups. However, the same
study group found that prolonged WI time of 120 minutes
produced signiﬁcant loss of renal function and mortality
[43].
Martin et al. [57] proved potential kidney WI tolerability
of up to 35 minutes in a single kidney monkey model.
Haischetal.[58]studiesindogmodelssuggestedthatthe
window of reversible WI injury could be as long as 2 hours
after the insult.
The question remains whether ﬁndings in animal studies
can be extrapolated to humans. One limitation has to do
with a reliable method to diﬀerentiate between ischemic
injury and the loss of renal volume secondary to tumor
excision. The ideal method to evaluate residual kidney
function in the operated kidney is still undeﬁned. While
most authors use serum creatinine assay or 99mtechnetium-
labeled mercaptoacetyl triglycine (MAG3) renal scintigraphy
with split renal function, others, like Abukora et al. [59]
proposed estimation of parenchymal transit time (PTT) as
a good indicator of ischemic injury. Transit time is the
time that a tracer remains within the kidney or within a
part of the kidney. However, the international consensus
committee on renal transit time, from the subcommittee
of the International Scientiﬁc Committee of Radionuclides
in Nephrourology, recently concluded that the value of
delayed transit remains controversial, and the committee
recommended further research [60].
Bhayani et al. [40] evaluated 118 patients, with a single,
unilateral, sporadic renal tumor, and normal contralateral
kidney, who underwent laparoscopic partial nephrectomy
(LPN) to assess the eﬀect of variable durations of WI on
long-termrenalfunction.Patientsweredividedinto3groups
b a s e do nW It i m e :g r o u p1 ,n or e n a lo c c l u s i o n( n = 42),
group 2, WI < 30 minutes (n = 48), and group 3, WI >
30 minutes (n = 28). At a median followup of 28 months
(minimum followup of 6 months) median creatinine had
not statistically increased postoperatively and none of the
118 patients progressed to renal insuﬃciency or required
dialysis after LPN. The authors concluded that WI time up
to 55 minutes did not signiﬁcantly inﬂuence long-term renal
function after LPN. A main limitation of this study has to
do with the fact that all patients had a normal contralateral
kidney so that 6 months postoperatively creatinine values
could have reﬂected contralateral kidney function.
A similar study has been conducted by Shekarriz et
al. [61] on a substantially lower number of patients (n =
17); however, the authors assessed kidney function using
99technetium labeled diethylenetetraminepentaacetic acid
scanrenalscanwithdiﬀerentialfunction1monthbeforeand
3monthsaftersurgeryinallpatients.Theauthorsfoundthat
all their patients preserved adequate renal function in the
aﬀected kidney following temporary hilar clamping of up to
44 minutes. (The mean WI time was 22.5 minutes.)
In line with this author, Kane et al. [62] showed that
temporary arterial occlusion did not appear to aﬀect short-
term renal function (mean followup: 130 days) in a series of
laparoscopic partial nephrectomies (LPNs) with a mean WI
of 43 minutes (range: 25–65 minutes).
Desai et al. [50] retrospectively assessed the eﬀect of WI
on renal function after LPN for tumor, and evaluated the
inﬂuence of various risk factors on renal function in 179
patients under WI conditions. No kidney was lost because
of ischemic sequelae with clamping of the renal artery andFernando P. Secin 5
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Nonetheless, the authors concluded that advancing age and
pre-existingazotaemiaincreasedtheriskofrenaldysfunction
after LPN, especially when the warm ischemia exceeded 30
minutes.
In contrast, Kondo et al. [63] found that patient age did
notinﬂuenceresidualfunctioninpatientsundergoingpartial
nephrectomy,whiletumorsizewastheonlysigniﬁcantfactor
that inversely correlated with the relative 99technetium
labeled dimercaptosuccinic acid (DMSA) uptake.
Porpigliaetal.[52]assessedkidneydamagein18patients
1y e a ra f t e rL P Nw i t haW It i m eb e t w e e n3 1a n d6 0
minutes. The authors evaluated the contribution of the
operated kidney to the overall renal function by radionuclide
scintigraphy with 99mTc-MAG3. They observed that there
was an initial signiﬁcant drop of approximately 11% in the
operated kidney’s contribution to overall function, followed
by a constant and progressive recovery that never reached
the preoperative value (42.8% at 1 year versus 48.3% before
surgery). The authors stated by logistic regression analysis
that the loss of function of the operated kidney depended
mostlyontheWItimeandlessimportantlyonthemaximum
thickness of resectedhealthyparenchyma.Unfortunately,the
full regression model that included 6 variables to predict an
event in only 18 patients is not shown in the manuscript.
Recently, Thompson et al. [42]m a d ear e t r o s p e c t i v e
review of 537 patients with solitary kidneys who underwent
open nephron sparing surgery by more than 20 diﬀerent
surgeons from both the Cleveland Clinic, Ohio, USA, and
Mayo Clinic, Minn, USA, to evaluate the renal eﬀects of
vascular clamping in patients with solitary kidneys. After
adjusting for tumor complexity and tumor size, the author
found in a subsequent analysis [64] that patients with more
than 20 minutes of WI were signiﬁcantly more likely to have
acute renal failure (24% versus 6%, p 0.002) compared to
those requiring less than 20 minutes, and this risk remained
signiﬁcant evenafteradjusting fortumorsize (odds ratio3.4,
p 0.025). Additionally, patients with more than 20 minutes
of WI were signiﬁcantly more likely to progress to chronic
renal failure (odds ratio 2.9, p 0.008) and were more than
4 times more likely to experience an increase in creatinine
postoperatively of greater than 0.5mg/dL (odds ratio 4.3, p
0.001) compared to those requiring less than 20 minutes of
WI. After adjusting for tumor size, the risk of chronic renal
failure (odds ratio 2.6, p 0.03) and an increase in creatinine
of greater than 0.5mg/dL (odds ratio 4.6, p 0.002) remained
statistically signiﬁcant if more than 20 minutes of WI were
needed. The authors concluded that WI should be restricted
to less than 20 minutes when technically feasible, especially
in patients with solitary kidneys.
5. WHAT ARE THE FACTORS AFFECTING
TOLERANCE TO WARM ISCHEMIA?
It often goes without saying that there may be individual
variation to WI tolerance. Baldwin et al. [37] observed that
some of the 16 solitary porcine kidneys showed a rapid
returntothedarkredcolor,andotheranimalsdemonstrated
minimal color change during the several minutes following
complete hilar clamp removal, despite all of them receiv-
ing similar surgical technique and ischemia time. Having
acknowledged the potential for individual variation, there
may be other multiple factors that can aﬀect tolerance to WI
which are herein described.
It has been suggested that patients with solitary kidneys
might safely tolerate longer periods of ischemia than patients
with both kidneys as the result of development of a collateral
vascular supply; [65–67] however, the presence of vascular
collateralization secondary to vascular occlusive disease, [68]
or yet other clinical entities like hypertension, [69] should
warn the surgeon for the possibility of a kidney less resistant
to WI injury for the likely presence of panvascular disease
and or occult chronic renal insuﬃciency.
Another factor that can impact ischemic damage is
the method employed to achieve vascular control of the
kidney. When technically possible, depending on the size
and location of the tumor, it is helpful to leave the
renal vein patent throughout the operation. This measure
has been proven to decrease intraoperative renal ischemia
and, by allowing venous backbleeding, facilitates hemostasis
by enabling identiﬁcation of small, transected renal veins
[1–3, 5].
Animal studies have shown that functional impairment
is least when the renal artery alone is occluded. Although
some authors found no diﬀerence [70] simultaneous occlu-
sion of the renal artery and vein for an equivalent time
interval is more damaging because it prevents, as mentioned,
retrograde perfusion of the kidney through the renal vein
and may also produce venous congestion of the kidney
[2, 3, 71–73] .H o w e v e r ,t h i sb e n e ﬁ tm a yn o tb eo b s e r v e d
in patients undergoing LRP since the pressure of the
pneumoperitoneum may cause partial occlusion of the renal
vein, thus, negating the advantage of renal artery clamping
only [72].
Intermittent clamping of the renal artery with short
periods of recirculation may also be more damaging than
continuous arterial occlusion, possibly because of the release
and trapping of damaging vasoconstrictor agents within the
kidney [39, 55, 71, 74–77].
Manual (or instrumental) compression of the kidney
parenchyma to control intraoperative hemorrhage (as an
alternative to clamping of the pedicle) has the theoretical
advantages of avoiding WI of the normal parenchyma while
allowing the surgeon to operate in an almost bloodless ﬁeld,
something that could be particularly useful in peripherically
locatedtumors.Althoughanimalstudieshaveshownthatthe
use of renal parenchyma compression may be more delete-
rious than simple arterial occlusion [71, 76], this technique
has been recently “resuscitated” by some authors both in the
open kidney surgery [78–82] and in the laparoscopic setting
[83].
When the surgeon anticipates a WI time exceeding the
“classical” 30 minutes, local renal hypothermia is used to
protect against ischemic renal injury. Hypothermia has been
the most eﬀective and universally used means of protecting
the kidney from the ischemic insult. Hypothermia reduces
basal cell metabolism, energy-dependent metabolic activity6 Advances in Urology
of the cortical cells, with a resultant decrease in both the
consumption of oxygen and ATP [84–86].
There are multiple ways of achieving hypothermia.
Surrounding the fully mobilized kidney with crushed ice
(ice slush) is the most frequently used technique because
of its ease and simplicity [87, 88]. When using ice slush
to reduce kidney temperature, it is recommended to keep
the entire kidney covered with ice for 10 to 15 minutes
immediately after occluding the renal artery and before
commencingtheresectionofthetumorinordertoallowcore
renal temperature to decrease to approximately 20 degrees
centigradeorless[2].Mannitol,withorwithouttheaddition
of furosemide, should be administered intravenously 5 to 15
minutes before renal arterial clamping as it increases renal
plasma ﬂow, decreases intrarenal vascular resistance and
intracellular edema, and promotes an osmotic diuresis when
renal circulation is restored [89]. Regular use of heparin to
prevent intrarenal vascular thrombosis has not been found
to be useful [2, 3, 56].
Other methods than the use of ice slush to achieve renal
hypothermia have also being explored, including application
of ice-slurry [90, 91], antegrade perfusion of the renal
artery either via preoperative renal artery catheterization
[92] or via intraoperative renal artery cannulation [93],
retrograde perfusion of the collecting system with cold
solutions [94, 95] or near-freezing saline irrigation delivered
with a standard irrigator aspirator [96] among others,
some of them particularly used in the laparoscopic setting.
Very few studies compared kidney cooling techniques; [97–
100] however, hypothermia by properly applying ice to
the renal surface seems to be equivalent to hypothermia
by perfusion [98]. Perfusion of the kidney with a cold
solution instilled via the renal artery not only may have
a theoretic risk of tumor dissemination, but also requires
participation of an intervention radiology team to perform
preoperative renal artery catheterization, adding complexity
and risks of potential complications to the procedure [3].
On the contrary, continuous renal perfusion might have the
advantage of providing a more homogeneous and eﬀective
hypothermia for a more extended period of time [99, 100]. It
is generally accepted, founded on data extrapolated from the
kidney stone literature, that adequate hypothermia provides
up to 2 to 3 hours of renal protection from circulatory arrest
[99, 101–104].
Needless to say, generous preoperative and intraoper-
ative hydration, prevention of intraoperative hypotension,
avoidance of unnecessary manipulation or traction on the
renal artery as well as the aforementioned administration
of mannitol are necessary to keep the kidney adequately
perfused before and after the ischemic insult.
Ischemicpreconditioning (IP)hasemergedas apowerful
method of ameliorating ischemia/reperfusion injury not
only the myocardium (as initially described) [105]b u t
also to other organs, including kidney. IP is a physiologic
phenomenon by which cells develop defense strategies to
allow them survive in a hypoxic environment. The original
IP hypothesis stated that multiple brief ischemic episodes
applied to an organ would actually protect it (originally
the myocardium) during a subsequent sustained ischemic
insult so that, in eﬀect, ischemia could be exploited to
protect that organ (originally the heart) from ischemic
injury[105].The“preconditioned”cellswouldbecomemore
tolerant to ischemia by adjusting its energy balance to a new,
lower steady-state equilibrium. Speciﬁcally, preconditioned
tissues exhibit reduced energy requirements, altered energy
metabolism, better electrolyte homeostasis and genetic reor-
ganization, giving rise to the conceptof “ischemia tolerance.”
IP also induces “reperfusion tolerance” with less reactive
oxygen species and activated neutrophils released, reduced
apoptosis and better microcirculatory perfusion compared
to not preconditioned tissue. Systemic reperfusion injury
is also diminished by preconditioning [31]. A review by
Pasupathy and Homer-Vanniasinkam [31] showed that IP
utilizes endogenous mechanisms in skeletal muscle, liver,
lung, kidney, intestine, and brain in animal models to convey
varying degrees of protection from reperfusion injury. To
date, there are few human studies, but some reports suggest
that human liver, lung, and skeletal muscle acquire similar
protection after IP. IP is ubiquitous but more research is
required to fully translate these ﬁndings to the clinical arena.
Some authors propose that during laparoscopy, the
increaseofintra-abdominalpressureduetothepneumoperi-
toneum may create an IP-like situation that might increase
kidney tolerance to subsequent WI and reduce tissue injury
[106–110]. For this reason, it might theoretically be possible
to increase WI time during LPN, compared to open surgery,
something which is still very far from being demonstrated
[30, 109–111].
In contrast, other studies expressed some concern about
the potential harm of pneumoperitoneum and increased
intra-abdominal pressure (IAP) on kidney function. Several
experimental animal studies have investigated the eﬀect of
pneumoperitoneum on renal function. While some authors
demonstrated that increased IAP by insuﬄation of CO2
gas resulted in decreased renal blood ﬂow that may lead to
ischemiaandsubsequentdecreasedglomerularﬁltrationrate
[112], others denied such eﬀect [37, 113].
Kirsch et al. [112] showed a decrease in urine output
and GFR with increasing IAP. A pneumoperitoneum of
15mmHg for 4 hours resulted in a decrease in renal blood
ﬂow to 70% of baseline. Even IAPs of 4 and 10mmHg
resulted in a reduction of the renal circulation of 34% and
41%, respectively. Although, the decreased urinary output
during prolonged IAP greater than or equal to 15mmHg
in the animal model was associated with a corresponding
decrease in renal vein ﬂow, it did not appear to be
associated with any permanent renal derangement nor any
transient histological changes [114]. After the release of the
pneumoperitoneum or pneumoretroperitoneum, the renal
function and urine output return to normal with no long-
termsequelae,eveninpatientswithpre-existingrenaldisease
[115].
Lind et al. [113] found that WI time of 20 minutes did
not impair graft function and histomorphology during 1
year of followup after renal transplantation in a syngeneic
rat model. Most important, WI in combination with pneu-
moperitoneum did not result in an additive negative eﬀect
on long-term graft function.Fernando P. Secin 7
In addition, Baldwin et al. [37] observed that temporary
serumcreatinineelevationevidentafter60and90minutesof
ischemianormalizedwithin7daysin16farmpigswhichhad
been nephrectomized 14 days prior to the laparoscopically
applied ischemic insult. No diﬀerence from the controls was
noted in those pigs receiving 30 minutes of ischemia during
the laparoscopic procedure. Of note, insuﬄation had been
maintained for 150 minutes at 15mmHg in all animals.
Those ﬁndings suggested that in laparoscopic renal surgery,
WI times of up to 90 minutes (and a pneumoperitoneum
of up to 150 minutes) might be well tolerated and followed
b yc o m p l e t er e n a lr e c o v e r y .T h er e a d e ri sr e f e r r e dt ot h e
excellent review by Dunn and McDougall [115] for further
information on the impact of pneumoperitoneum on renal
physiology.
6. CONCLUSIONS
The maximal duration of WI allowable before the onset
of irreversible renal damage continues to be a topic of
debate, irrespective of the surgical approach. In addition,
there seems to be variation among patients, possibly related
to surgical technique, patient age, presence of collateral
vascularization, and indemnity of the arterial bed, among
others. Unfortunately, no method exists for predicting
preoperatively or intraoperative monitoring for renal injury.
Surgeonsshouldexertextremeeﬀortstokeepwarmischemia
time as short as possible. When WI time is expected to
exceed from 20 to 30 minutes, specially in patients whose
baseline medical characteristics put them at potentially
higher, though unproven, risks of ischemic damage, the
time-tested way around this time limit has been renal
hypothermia, regardless of what the time limit may exactly
be.
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